Document:

Exhibit

ELEVENTH AMENDMENT OF 
2013 LOAN AND SECURITY AGREEMENT

THIS ELEVENTH AMENDMENT OF 2013 LOAN AND SECURITY AGREEMENT (“Eleventh Amendment”) is made as of the 30th day of September, 2017 (the “Effective Date”) by and among ADA-ES, INC., a Colorado corporation (“Borrower”), ADVANCED EMISSIONS SOLUTIONS, INC., a Delaware corporation (“ADES”), and COBIZ BANK, a Colorado corporation, d/b/a COLORADO BUSINESS BANK (“Lender”).
RECITALS
A.    Borrower, ADES and Lender are parties to that certain 2013 Loan and Security Agreement dated as of September 19, 2013 (as amended, supplemented, modified and restated from time to time, the “Loan Agreement”).
B.    In accordance with the provisions of the Loan Agreement, Lender has agreed to amend, for the benefit of Borrower, certain terms and conditions contained in the Loan Agreement, as specifically provided herein.
C.    ADES wishes to provide its consent to the amendments set forth herein.
D.    Other than as defined in this Eleventh Amendment, all capitalized terms used in this agreement without definition shall have the meanings given to such terms in the Loan Agreement.
NOW THEREFORE, in consideration of the promises and covenants made by Borrower and contained in this Eleventh Amendment and the consent given by ADES herein, Lender agrees to the amendments set forth below as of the Effective Date: 
1.Amendments to Definitions.  The following definitions are amended and restated in their entirety, to read as follows:
“EBITDA” means for any Measurement Period, with respect to Borrower and its Subsidiaries on a consolidated basis, in accordance with GAAP, net income for such period (i) plus, without duplication and to the extent deducted in calculating net income, the sum of (a) interest expense, (b) the sum of federal, state, local and foreign taxes paid in cash, (c) depreciation and amortization expense, (d) subject to Lender’s approval, which shall not be unreasonably withheld, any extraordinary, unusual or non-recurring items, and, (e) any other non-cash items; (ii) minus, without duplication and to the extent added in calculating net income, the sum of (a) any extraordinary, unusual or non-recurring items, including without limitation all income from the sale of activated carbon injection and dry sorbent injection equipment systems, and (b) any non-cash items.
 “Maximum Secured Line” means Ten Million Dollars ($10,000,000).
“Secured Line Termination Date” means September 30, 2018, or such earlier date as may occur pursuant to Section 8.2 hereof.

2.    Amendment of Exhibits.  Exhibit C and Exhibit F to the Loan Agreement are each amended and restated to read, respectively, in their entirety, as attached hereto. 

3.    Letter of Credit Facility.  Section 2.11(a) is amended and restated to read as follows:
(a)    Subject to the terms and conditions of this Agreement and the other Loan Documents, the Secured Line may be utilized, upon request of Borrower, in addition to the Advances, for the issuance of Letters of Credit by Lender provided, however, that in no event shall:

(i)    the aggregate amount of the Letters of Credit exceed at any time the sum of Eight Million Dollars ($8,000,000);
(ii)    the aggregate amount of the Letters of Credit, plus the aggregate principal amount of all Advances then outstanding, exceed at any time the Borrowing Base;
(iii)    the expiration date of any Letter of Credit extend beyond the Maturity Date;
(iv)    Lender be obligated to issue any Letter of Credit at any time while there then exists and is continuing any Default or Event of Default; nor
(v)    any Letter of Credit be issued in a currency other than United States Dollars nor at a tenor other than sight.

4.    Promise to Pay Fees.  Section 3.2 is amended and restated in its entirety to read as follows:
(a)    Borrower shall pay Lender, on or before execution hereof, a loan origination fee of Twenty-Five Thousand Dollars ($25,000); and
(b)    Borrower shall pay Lender an annual unused commitment fee equal to .75% of the averaged unused portion of the Maximum Secured Line payable monthly in arrears commencing on November 1, 2017 (the “Non-Use Fee”).  For the purpose of calculating the Non-Use Fee, the Letters of Credit issued hereunder shall be deemed to be a use of the Maximum Secured Line.
5.    Litigation.  Section 5.6 is amended and restated in its entirety to read as follows:

Other than the arbitration award issued on April 8, 2011 in favor of Norit Americas, Inc. and Norit International, N.V., and the related subsequent confidential settlement agreement dated August 29, 2011 and indemnity settlement agreement dated November 28, 2011, the material terms of which have

2

 been disclosed to Lender (“Settlement Agreements”), there are no actions, suits, proceedings, or investigations pending or, to the knowledge of Borrower or ADES, threatened against Borrower which, if adversely determined, would, in any case or in the aggregate, have a Material Adverse Effect.
6.    Financial Covenants.  Section 6.12, entitled “Minimum Balance Covenant,” is hereby deleted.  

7.    No Default.  Borrower and ADES hereby certify to Lender that, after giving effect to the amendments and waivers provided herein, Borrower is in full compliance with the provisions of the Loan Agreement, and that no Event of Default will occur as a result of the effects of this Eleventh Amendment. 

8.    Release of Claims.  Borrower and ADES hereby release and forever discharge Lender, its affiliates, directors, officers, agents, employees, and attorneys (“Lender Parties”) of and from any and all liability, suits, damages, claims, counterclaims, demands, reckonings and causes of action, setoffs and defenses, whether known or unknown, whether arising in law or equity, which any of Borrower or ADES have, now have or may have in the future against Lender Parties by reason of any acts, omissions, causes or things arising out of or in any way related to this Eleventh Amendment or the Loan Agreement existing or accrued as of the date of this Eleventh Amendment.  This release shall survive the termination of this Eleventh Amendment.  Borrower acknowledges that the foregoing release is a material inducement to Lender’s decision to extend to Borrower the financial accommodations hereunder and has been relied upon by Lender in its agreement to enter into this Eleventh Amendment.
9.    Costs.  Borrower will pay Lender’s attorneys’ fees for preparation of this Eleventh Amendment and all reasonable costs and expenses of Lender in connection therewith.
10.    Miscellaneous.
		
	(a)
	The paragraph headings used herein are intended for reference purposes only and shall not be considered in the interpretation of the terms and conditions hereof.

		
	(b)
	The terms and conditions of this Eleventh Amendment shall be binding upon and shall inure to the benefit of the parties hereto, their successors and permitted assigns.

		
	(c)
	This Eleventh Amendment may be executed in any number of counterparts, and by Lender, ADES and Borrower on separate counterparts, each of which, when so executed and delivered, shall be an original, but all of which shall together constitute one and the same agreement.

		
	(d)
	Except as expressly modified by this Eleventh Amendment, the Loan Agreement shall remain in full force and effect and shall be enforceable in accordance with its terms.

3

		
	(e)
	This Eleventh Amendment and the Loan Agreement constitute the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersede all prior negotiations, understandings, and agreements between such parties with respect to such subject matter. 

		
	(f)
	This Eleventh Amendment, and the transactions evidenced hereby, shall be governed by, and construed under, the internal laws of the State of Colorado, without regard to principles of conflicts of law, as the same may from time to time be in effect, including, without limitation, the Uniform Commercial Code as in effect in the State of Colorado.

(Signatures on following page)

4

IN WITNESS WHEREOF, the parties hereto have executed and delivered this Eleventh Amendment as of the date first above set forth.

	
			
	 
	 
	ADA-ES, INC.,

	 
	 
	a Colorado corporation

	 
	 
	 

	 
	 
	 

	
			
	 
	By:
	/s/ L. Heath Sampson

	 
	Name:
	L. Heath Sampson

	 
	Title:
	President

	 
	 
	 

	
			
	 
	 
	ADVANCED EMISSIONS SOLUTIONS, INC.,

	 
	 
	a Delaware corporation

	 
	 
	 

	 
	 
	 

	
			
	 
	By:
	/s/ L. Heath Sampson

	 
	Name:
	L. Heath Sampson

	 
	Title:
	CEO

	 
	 
	 

 
440469

Signature Page to Eleventh Amendment of 2013 Loan and Security Agreement

IN WITNESS WHEREOF, the parties hereto have executed and delivered this Eleventh Amendment as of the date first above set forth.

	
			
	 
	 
	COBIZ BANK,

	 
	 
	a Colorado corporation,

	 
	 
	d/b/a COLORADO BUSINESS BANK

	 
	 
	 

	
			
	 
	By:
	/s/ Paul D. Stanford

	 
	 
	Paul D. Stanford, Senior Vice President

	 
	 
	 

	 
	 
	 

400469

Signature Page to Eleventh Amendment of 2013 Loan and Security Agreement

EXHIBIT C
BORROWING BASE CERTIFICATE
(Revised 9/30/2017)

As of the period ending              , 20    

This Certificate is made and dated as of                 , 20     and is submitted by ADA-ES, INC., a Colorado corporation, in accordance with the 2013 Loan and Security Agreement by and among ADA-ES, INC., ADVANCED EMISSIONS SOLUTIONS, INC., and COBIZ Bank, a Colorado corporation, d/b/a Colorado Business Bank (as amended, modified, supplemented and restated from time to time, the “Loan Agreement”).  Capitalized terms used but not defined herein shall have the respective meanings therefor set forth in the Loan Agreement.

The undersigned hereby certifies to Lender that the undersigned is familiar with the following financial information, which has been taken from Borrower’s books and records, which are complete and accurate, and the following calculations on the Borrowing Base and the remaining amount under the Borrowing Base are true and correct.

BORROWING BASE
(All numbers must be taken from the most recent 10-K or 10-Q filed by ADES with the Securities and Exchange Commission.)

	
		
	A.   Total fixed payments due to Borrower by CCS n/k/a Tinuum Group, LLC on the AECI Leases
	 

	B.   Balance in A discounted to present value using a discount factor of ten percent (10%)*
	 

	C.   Eighty percent (80%) of B
	 

	D.   Total Available Collateral:  C or $10,000,000, whichever is less
	 

	E.    Current Secured Line Balance of $____________ plus the aggregate amount of outstanding Letters of Credit of $________________)
	 

	F.   Excess / (Deficit) Borrowing Base (D minus E)
	 

*Spreadsheet used to calculate present value attached.

	
			
	 
	 
	ADA-ES, INC.,

	 
	 
	a Colorado corporation

	 
	 
	 

	 
	 
	 

	
			
	 
	By:
	 

	 
	Name:
	 

	 
	Title:
	 

	 
	 
	 

Exhibit C

EXHIBIT F
FORM OF COMPLIANCE CERTIFICATE
(Revised 9/30/2017)

ADA-ES, INC., a Colorado corporation (“Borrower”), and ADVANCED EMISSIONS SOLUTIONS, INC., a Delaware corporation (“ADES”), hereby certify to COBIZ BANK, a Colorado corporation, d/b/a COLORADO BUSINESS BANK (“Lender”) pursuant to the 2013 Loan and Security Agreement by and among Borrower, ADES and Lender (as amended, modified, supplemented and restated from time to time, the “Loan Agreement”), that:

A.General.

1.Capitalized terms not defined herein shall have the meanings set forth in the Loan Agreement.

2.Borrower has materially complied with the terms, covenants and conditions to be performed or observed by Borrower contained in the Loan Agreement and the Loan Documents.

3.Neither on the date hereof nor, if applicable, after giving effect to any Advance made under the Loan Agreement on the date hereof, does there exist an Event of Default.

		
	B.
	Financial Covenants.  (All numbers must be taken from the most recent 10 K or 10-Q filed by ADES with the Securities and Exchange Commission.)

1.Minimum EBITDA Covenant:
	
		
	A.   Consolidated net income for the Measurement Period of ADES and its Subsidiaries
	 

	without duplication and to the extent deducted in calculating Net Income in A:
	 

	B.   interest expense
	 

	C.   the sum of federal, state, local and foreign taxes paid in cash
	 

	D.   depreciation and amortization expense
	 

	E.   any extraordinary, unusual or non-recurring items
	 

	F.   any other non-cash items
	 

	G.   Total of A+B+C+D+E+F
	 

	   without duplication and to the extent deducted in calculating Net Income in A:
	 

	H.    any extraordinary, unusual or non-recurring items, including without limitation all income from the sale of activated carbon injection and dry sorbent injection equipment systems
	 

	I.   any other non-cash items
	 

	J.   Total of H+I
	 

	K.   G less J 
	 

	L.   Is K greater than or equal to $24,000,000
	yes/no

Exhibit F, Page 1

IN WITNESS WHEREOF, Borrower and ADES have executed and delivered this Compliance Certificate on             , 20___.

	
				
	ADA-ES, INC., a Colorado corporation
	ADVANCED EMISSIONS SOLUTIONS, INC., a Delaware corporation

	 
	 
	 
	 

	By:
	 
	By:
	 

	Its:
	 
	Its:
	 

Exhibit F, Page 2Exhibit
10.2 

 

RESTRICTED
STOCK AWARD AGREEMENT

 

This
Restricted Stock Award Agreement (this “Agreement”) sets forth the terms of a Restricted Stock Award granted
on __________________ (“Effective Date”) by Sensus Healthcare, Inc., a Delaware corporation (“Sensus”)
to _________________________ (“Grantee”). Capitalized terms used but not defined in this Agreement have the
meanings ascribed to them in the Plan (as defined below).

 

RECITALS

 

A.       The
Company adopted that 2017 Equity Incentive Plan (“Plan”) pursuant to which the Company may grant
Restricted Stock Awards to Key Persons.

 

B.       The
Committee has determined that it is in the best interests of the Company and its stockholders to grant Restricted Stock to the
Grantee in accordance with the terms and conditions of this Agreement.

 

C.       Grantee
wishes to accept such grant of Restricted Stock on the terms and subject to the conditions set forth in this Agreement.

 

NOW,
THEREFORE, in consideration of the mutual promises set forth in this Agreement, and for other good and valuable consideration,
the adequacy of which is acknowledged by the parties’ execution of this Agreement, the Company and the Grantee agree as follows:

 

1.     
Grant of Restricted Stock. Pursuant to Article 5 of the Plan, the Company has granted to the Grantee on the Effective
Date a Restricted Stock Grant consisting of, in the aggregate, _____________ shares of Common Stock of the Company, on the terms
and conditions and subject to the restrictions set forth in this Agreement and the Plan. This grant of the Restricted Stock is
made in consideration of the services rendered and to be rendered by the Grantee to the Company.

 

2.     
Restricted Period; Vesting. 

 

a.      
Vesting Schedule. Except as otherwise provided in this Agreement, provided that the Grantee remains in Continuous Service
(as defined below) through the applicable vesting date[, and further provided that any additional conditions and Performance Goals
set forth in Schedule A have been satisfied], the Restricted Stock will vest in accordance with the following schedule:

 

	 	Vesting
    Date	Shares
    of Common Stock
	 	 	 
	 	[DATE]	[NUMBER
    OR % OF SHARES]
	 	 	 
	 	[DATE]	[NUMBER
    OR % OF SHARES]
	 	 	 
	 	[DATE]	[NUMBER
    OR % OF SHARES]
	 	 	 
	 	[DATE]
    (the “Final Vesting Date”)	[NUMBER
    OR % OF SHARES]

 

    	1 

     

    

 

The
period from the Effective Date through the Final Vesting Date is referred to as the “Restricted Period.” For
purposes of this Agreement, “Continuous Service” means the Grantee’s service with the Company, whether
as an employee, consultant or director, is not interrupted or terminated. The Grantee’s Continuous Service shall not be
deemed to have terminated merely because of a change in the capacity in which the Grantee renders service to the Company as an
employee, consultant or director or a change in the entity for which the Grantee renders such service, provided that there is
no interruption or termination of the Grantee’s Continuous Service; and provided further that if any Award is subject to
Section 409A of the Code, this sentence shall only be given effect to the extent consistent with Section 409A of the Code. The
Committee, in its sole discretion, may determine whether Continuous Service shall be considered interrupted in the case of any
leave of absence by the Grantee, including sick leave, military leave or any other personal or family leave of absence.

 

b.     
Termination of Continuous Service. Except as set forth in this Agreement, the foregoing vesting schedule notwithstanding,
if the Grantee’s Continuous Service terminates for any reason at any time before all of his or her Restricted Stock has
vested, the Grantee’s unvested Restricted Stock shall be automatically forfeited upon such termination of Continuous Service
and the Company shall have no further obligations to the Grantee under this Agreement. Neither the Plan nor this Agreement shall
confer upon the Grantee any right to be retained in any position, as an employee, consultant or director of the Company. Further,
nothing in the Plan or this Agreement shall be construed to limit the discretion of the Company to terminate the Grantee’s
Continuous Service at any time, with or without Cause.

 

c.      
Change of Control. The foregoing vesting schedule notwithstanding, upon the occurrence of a Change in Control, 100% of
the unvested Restricted Stock shall vest as of the date of the Change in Control. 

 

d.     
Death or Disability. The foregoing vesting schedule notwithstanding, if the Grantee’s Continuous Service terminates
as a result of death or Disability of the Grantee, then any unvested Restricted Stock that would have vested within one (1) year
from the date of termination (or within such other period as determined by the Committee) shall vest as of the date of termination.

 

e.      
Termination without Cause. The foregoing vesting schedule notwithstanding, if the Grantee’s Continuous Service terminates
as a result of voluntary resignation by the Grantee or termination by the Company without Cause, then any unvested Restricted
Stock that would have vested within thirty (30) days from the date of termination (or within such other period as determined by
the Committee) shall vest as of the date of termination.

 

		3.	Restrictions.
                                         

 

a.      
Transfer Restriction. Subject to any exceptions set forth in this Agreement or the Plan, during the Restricted Period,
the Restricted Stock or the rights relating thereto may not be assigned, alienated, pledged, attached, sold or otherwise transferred
or encumbered by the Grantee. Any attempt to assign, alienate, pledge, attach, sell or otherwise transfer or encumber the Restricted
Stock or the rights relating thereto during the Restricted Period shall be wholly ineffective and, if any such attempt is made,
the Restricted Stock will be forfeited by the Grantee and all of the Grantee’s rights to such shares shall immediately terminate
without any payment or consideration by the Company. 

 

b.     
Effect of Prohibited Transfer. The Company shall not be required to (i) transfer on its books any shares of Restricted
Stock that have been transferred in violation of any of the provisions set forth in this Agreement, or (i) treat as owner of such
Restricted Stock or to pay dividends or other distributions to any transferee to whom any such Restricted Stock shall have been
so sold or transferred.

 

		4.	Rights
                                         as a Stockholder; Dividends.

 

a.      
Stockholder Rights. The Grantee shall be the record owner of the Restricted Stock (including unvested Restricted Stock)
granted under this Agreement until the shares are sold or otherwise disposed of, and shall be entitled to all of the rights of
a stockholder of the Company including, without limitation, the right to vote such shares and receive all dividends or other distributions
paid with respect to such shares. Notwithstanding the foregoing, (i) any dividends or other distributions shall be subject to
the same restrictions on transferability as the shares of Restricted Stock with respect to which they were paid; and (ii) any
dividends or other distributions paid by the Company with respect to any shares of Restricted Stock shall accrue but shall not
be payable unless and until vesting of such Restricted Stock, at which time the accumulated dividends shall be paid by the Company.

 

    	2 

     

    

 

b.     
Stock Certificates. The Company may, but need not, issue stock certificates or evidence the Grantee’s interest by
using a restricted book entry account with the Company’s transfer agent. 

 

c.      
Forfeiture. If the Grantee forfeits any rights he or she has under this Agreement in pursuant to Section 3, the Grantee
shall, on the date of such forfeiture, no longer have any rights as a stockholder with respect to any unvested Restricted Stock
and shall no longer be entitled to vote or receive dividends on such shares.

 

5.     
Tax Liability and Withholding.

 

a.      
Payment of Taxes. The Grantee shall be required to pay to the Company, and the Company shall have the right to deduct from
any compensation paid to the Grantee pursuant to this Agreement, the amount of any required withholding taxes in respect of the
Restricted Stock granted under this Agreement and to take all such other action as the Committee deems necessary to satisfy all
obligations for the payment of such withholding taxes. The Committee may permit the Grantee to satisfy any federal, state or local
tax withholding obligation by any of the following means, or by a combination of such means: (i) tendering a cash payment; (ii)
authorizing the Company to withhold shares of Common Stock from the shares of Common Stock otherwise issuable or deliverable to
the Grantee as a result of the vesting of the Restricted Stock; provided, however, that no shares of Common Stock shall be withheld
with a value exceeding the minimum amount of tax required to be withheld by law; or (iii) delivering to the Company previously
owned and unencumbered shares of Common Stock.

 

b.     
Liability. Notwithstanding any action the Company takes with respect to any or all income tax, social insurance, payroll
tax, or other tax-related withholding (“Tax-Related Items”), the ultimate liability for all Tax-Related Items
is and remains the Grantee’s responsibility and the Company (a) makes no representation or undertakings regarding the treatment
of any Tax-Related Items in connection with the grant or vesting of the Restricted Stock or the subsequent sale of any shares;
and (b) does not commit to structure the Restricted Stock to reduce or eliminate the Grantee’s liability for Tax-Related
Items.

 

6.     
Section 83 Election. The Grantee may make an election under Code Section 83(b) (a “Section 83(b) Election”)
with respect to the Restricted Stock granted under this Agreement. Any such election must be made within thirty (30) days after
the Effective Date. If the Grantee elects to make a Section 83(b) Election, the Grantee shall provide the Company with a copy
of an executed version and satisfactory evidence of the filing of the executed Section 83(b) Election with the US Internal Revenue
Service. The Grantee agrees to assume full responsibility for ensuring that the Section 83(b) Election is actually and timely
filed with the US Internal Revenue Service and for all tax consequences resulting from the Section 83(b) Election.

 

    	3 

     

    

 

7.     
Compliance with Law.

 

a.      
Compliance. The issuance and transfer of shares of Restricted Stock granted under this Agreement shall be subject to compliance
by the Company and the Grantee with all applicable requirements of federal and state securities laws and with all applicable requirements
of any stock exchange on which the Company’s shares of Common Stock may be listed. No shares of Restricted Stock granted under
this Agreement shall be issued or transferred unless and until any then applicable requirements of state and federal laws and
regulatory agencies have been fully complied with to the satisfaction of the Company and its counsel. The Grantee understands
that the Company is under no obligation to register the shares of Common Stock with the Securities and Exchange Commission, any
state securities commission or any stock exchange to effect such compliance.

 

b.     
Legend. A legend may be placed on any certificate(s) or other document(s) delivered to the Grantee indicating restrictions
on transferability of the shares of Restricted Stock pursuant to this Agreement or any other restrictions that the Committee may
deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any applicable federal
or state securities laws or any stock exchange on which the shares of Common Stock are then listed or quoted.

 

		8.	Miscellaneous.

 

a.      
Interpretation. Any dispute regarding the interpretation of this Agreement shall be submitted by the Grantee or the Company
to the Committee for review. The resolution of such dispute by the Committee shall be final and binding on the Grantee and the
Company. In the event of any inconsistency between the terms and conditions of this Agreement and any existing employment agreement,
service contract or other agreement between the Grantee and the Company (each, a “Service Agreement”), the
terms and conditions of the Service Agreement shall control.

 

b.     
Restricted Stock Subject to the Plan. This Agreement is subject to the Plan as approved by the Company’s stockholders,
as the Plan may be amended from time to time, and the terms and provisions of the Plan, as it may be amended from time to time,
are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term
or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail. 

 

c.      
Discretionary Nature of the Plan. The Plan is discretionary and may be amended, cancelled or terminated by the Company
at any time, in its discretion. The grant of the Restricted Stock in this Agreement does not create any contractual right or other
right to receive any Restricted Stock or other Awards in the future. Future Awards, if any, will be at the sole discretion of
the Company. Any amendment, modification, or termination of the Plan shall not constitute a change or impairment of the terms
and conditions of the Grantee’s employment or engagement with the Company. 

 

d.     
No Impact on Other Benefits. The value of the Grantee’s Restricted Stock granted under this Agreement is not part
of his normal or expected compensation for purposes of calculating any severance, retirement, welfare, insurance or similar employee
benefit.

 

e.      
Acceptance. The Grantee hereby acknowledges receipt of a copy of the Plan and this Agreement. The Grantee has read and
understands the terms and provisions this Agreement and the Plan, and accepts the Restricted Stock granted under this Agreement
subject to all of the terms and conditions of the Plan and this Agreement. The Grantee acknowledges that there may be tax consequences
upon the grant or vesting of the Restricted Stock granted under this Agreement and/or the disposition of the underlying shares
and that the Grantee has been advised to consult a tax advisor prior to such grant, vesting or disposition.

 

f.      
Gunster, Yoakley & Stewart, P.A. Represents the Company. The Grantee acknowledges and agrees that Gunster, Yoakley
& Stewart, P.A., a Florida professional association (“Gunster Yoakley”) represents the Company and not
the Grantee. Grantee acknowledges that Gunster Yoakley has not represented him or her in connection with this Agreement and that
he or she has been advised to engage legal counsel to advise him or her regarding this Agreement.

 

    	4 

     

    

 

g.      
Further Instruments. The Company and the Grantee agree to execute such further instruments and to take such further action
as may reasonably be necessary to carry out the intent of this Agreement.

 

h.     
Notices. Any notice required to be delivered to the Company under this Agreement shall be in writing and addressed to the
Chief Financial Officer of the Company at the Company’s principal corporate offices. Any notice required to be delivered
to the Grantee under this Agreement shall be in writing and addressed to the Grantee at the Grantee’s address as shown in
the records of the Company. Either party may designate another address by delivering notice of such designation in accordance
with this Section.

 

i.       
Governing Law, Venue and Jurisdiction. This Agreement shall be governed in all respects by the laws of the State of Florida
without regard to conflicts-of-law principles. Any civil action or legal proceeding arising out of or relating to this Agreement
shall be brought in the courts of record of the State of Florida in Palm Beach County, Florida. Each party consents to the jurisdiction
of such Florida court in any such civil action or legal proceeding and waives any objection to the laying of venue of any such
civil action or legal proceeding in such Florida court. Service of any court paper may be affected on such party by mail, as provided
in this Agreement, or in such other manner as may be provided under applicable laws, rules of procedure or local rules. 

 

j.       
Assignment. The Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure
to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth in this Agreement,
this Agreement will be binding upon the Grantee and the Grantee’s beneficiaries, executors, administrators and the person(s)
to whom the Restricted Stock may be transferred by will or the laws of descent or distribution.

 

k.     
Amendment. The Committee has the right to amend, alter, suspend, discontinue or cancel the Restricted Stock granted under
this Agreement, prospectively or retroactively; provided, that, no such amendment, nor any amendment to the Plan, shall adversely
affect the Grantee’s material rights under this Agreement without the Grantee’s consent. 

 

l.       
Severability. The invalidity or unenforceability of any provision of the Plan or this Agreement shall not affect the validity
or enforceability of any other provision of the Plan or this Agreement, and each provision of the Plan and this Agreement shall
be severable and enforceable to the extent permitted by law.

 

m.   
Waiver. No delay or omission by the Company in exercising any right under this Agreement shall operate as a waiver of that
or any other right. A waiver or consent given by the Company on any one occasion shall be effective only in that instance and
shall not be construed as a bar or waiver of any right on any other occasion.

 

    	5 

     

    

 

n.     
JURY WAIVER. IN ANY CIVIL ACTION, COUNTERCLAIM, OR PROCEEDING, WHETHER AT LAW OR IN EQUITY, WHICH ARISES OUT OF, CONCERNS,
OR RELATES TO THIS AGREEMENT, ANY AND ALL TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, THE PERFORMANCE OF THIS AGREEMENT, OR THE
RELATIONSHIP CREATED BY THIS AGREEMENT, WHETHER SOUNDING IN CONTRACT, TORT, STRICT LIABILITY, OR OTHERWISE, TRIAL SHALL BE TO
A COURT OF COMPETENT JURISDICTION AND NOT TO A JURY. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY
JURY. ANY PARTY MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS AGREEMENT WITH ANY COURT, AS WRITTEN EVIDENCE OF THE CONSENT
OF THE COMPANY AND GRANTEE OF THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. NEITHER PARTY HAS MADE OR RELIED UPON ANY ORAL REPRESENTATIONS
TO OR BY ANY OTHER PARTY REGARDING THE ENFORCEABILITY OF THIS PROVISION. EACH PARTY HAS READ AND UNDERSTANDS THE EFFECT OF THIS
JURY WAIVER PROVISION. EACH PARTY ACKNOWLEDGES THAT IT HAS BEEN ADVISED BY ITS OWN COUNSEL WITH RESPECT TO THE TRANSACTION GOVERNED
BY THIS AGREEMENT AND SPECIFICALLY WITH RESPECT TO THE TERMS OF THIS SECTION.

 

o.     
Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, and a complete
set of which, when taken together, shall constitute one and the same document. Confirmation of execution by electronic transmission
of a facsimile or .pdf signature page shall be binding, and each party hereby irrevocably waives any objection that it has or
may have in the future as to the validity of any such electronic transmission of a signature page.

 

p.     
Entire Agreement. This Agreement, together with the attached Schedule A and the Plan, constitutes the sole and entire agreement
of the parties with respect to the subject matter of this Agreement and supersedes all prior and contemporaneous understandings,
agreements, representations and warranties, both written and oral, with respect to such subject matter.

 

The
Company and the Grantee have executed this Restricted Stock Award Agreement as of the Effective Date.

 

	COMPANY:	GRANTEE:
	 	 
	SENSUS
    HEALTHCARE, INC.	[NAME]
	 	 
	By:_________________________________	 	 	 
	Name:_______________________________	 	 
	Title:________________________________	 	 

 

    	6 

     

    

 

Schedule
A

Additional
Conditions and Performance Goals

 

    	7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}]]